Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
View ORCID ProfileAmanda C Perofsky, John Huddleston, Chelsea Hansen, John R Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E Wentworth, Nicola Lewis, Lynne Whittaker, Burcu Ermetal, Ruth Harvey, Monica Galiano, Rodney Stuart Daniels, John W McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Sheena G Sullivan, Ian G Barr, Kanta Subbarao, Florian Krammer, Trevor Bedford, Cécile Viboud
doi: https://doi.org/10.1101/2023.10.02.23296453
Amanda C Perofsky
1Fogarty International Center, National Institutes of Health, United States
2Brotman Baty Institute for Precision Medicine, University of Washington, United States
John Huddleston
3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, United States
Chelsea Hansen
1Fogarty International Center, National Institutes of Health, United States
2Brotman Baty Institute for Precision Medicine, University of Washington, United States
John R Barnes
4Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States
Thomas Rowe
4Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States
Xiyan Xu
4Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States
Rebecca Kondor
4Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States
David E Wentworth
4Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States
Nicola Lewis
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
Lynne Whittaker
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
Burcu Ermetal
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
Ruth Harvey
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
Monica Galiano
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
Rodney Stuart Daniels
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
John W McCauley
5WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom
Seiichiro Fujisaki
6Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Kazuya Nakamura
6Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Noriko Kishida
6Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Shinji Watanabe
6Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Hideki Hasegawa
6Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
Sheena G Sullivan
7WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia
Ian G Barr
7WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia
Kanta Subbarao
7WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia
Florian Krammer
8Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, United States
9Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, United States
Trevor Bedford
2Brotman Baty Institute for Precision Medicine, University of Washington, United States
3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, United States
10Department of Genome Sciences, University of Washington, United States
11Howard Hughes Medical Institute, Seattle, United States
Cécile Viboud
1Fogarty International Center, National Institutes of Health, United States
- Supplementary file 1[supplements/296453_file02.xlsx]
Posted May 22, 2024.
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
Amanda C Perofsky, John Huddleston, Chelsea Hansen, John R Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E Wentworth, Nicola Lewis, Lynne Whittaker, Burcu Ermetal, Ruth Harvey, Monica Galiano, Rodney Stuart Daniels, John W McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Sheena G Sullivan, Ian G Barr, Kanta Subbarao, Florian Krammer, Trevor Bedford, Cécile Viboud
medRxiv 2023.10.02.23296453; doi: https://doi.org/10.1101/2023.10.02.23296453
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
Amanda C Perofsky, John Huddleston, Chelsea Hansen, John R Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E Wentworth, Nicola Lewis, Lynne Whittaker, Burcu Ermetal, Ruth Harvey, Monica Galiano, Rodney Stuart Daniels, John W McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Sheena G Sullivan, Ian G Barr, Kanta Subbarao, Florian Krammer, Trevor Bedford, Cécile Viboud
medRxiv 2023.10.02.23296453; doi: https://doi.org/10.1101/2023.10.02.23296453
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12604)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (620)
- Oncology (2218)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)